Literatur
-
1 Sass H, Wittchen H U, Zaudig M. Diagnostisches und Statistisches Manual Psychischer Störungen. - DSM-IV. Göttingen: Hogrefe 1996
-
2
Folstein M F, Folstein S E, McHugh P R.
„Mini-Mental-State”.
J Psychiatr Res.
1975;
12
189-198
-
3 Calabrese P, Kessler J. DemTect zur Demenzdiagnostik. Testvorlage Karlsruhe: Pfizer & Frankfurt: Esai 2000
-
4 Ihl R, Weyer G. Alzheimer's Disease Assessment Scale (ADAS). Deutsche Bearbeitung. Weinheim: Beltz 1993
-
5
Reisberg B, Finkel S, Overall J. et al .
The Alzheimer's disease activities of daily living international scale (ADL-IS).
Int Psychogeriatr.
2001;
13
163-181
-
6
Petersen R C, Doody R, Kurz A.
Current concepts in mild cognitive impairment.
Arch Neurol.
2001;
58
1985-1992
-
7
Hulstaert F, Blennow K, Ivanoui A. et al .
Improved discrimination of AD patients using beta-amyloid (1 - 42) and tau levels in CSF.
Neurology.
1999;
52
1555-1562
-
8
Lobotesis K, Fenwick J D, Phipps A. et al .
Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD.
Neurology.
2001;
56
643-649
-
9
Minoshima S, Foster M L, Sima A A. et al .
Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation.
Ann Neurol.
2001;
50
358-365
-
10
Campion D, Dumanchin C, Hannequin D. et al .
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.
Am J Hum Genet.
1999;
65
664-670
-
11
Hy L X, Keller D M.
Prevalence of AD among whites: a summary by levels of severity.
Neurology.
2000;
55
198-204
-
12
Nussbaum R L, Ellis C E.
Alzheimer's disease and Parkinson's disease.
N Engl J Med.
2003;
348
1356-1364
-
13
Barber R, Panikkar A, McKeith I G.
Dementia with Lewy bodies: diagnosis and treatment.
Int J Geriatr Psychiatry.
2001;
16
S12-S18
-
14
McKeith I G, Galasko G, Kosaka K. et al .
Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB).
Neurology.
1996;
47
1113-1124
-
15
Wallesch C W.
Leitlinien zur Diagnostik bei Patienten mit Demenz.
Akt Neurol.
2001;
28
201-207
-
16
Papka M, Rubio A, Schiffer R B.
A review on Lewy body disease, an emerging concept of cortical dementia.
J Neuropsychiatr Clin Neurosci.
1998;
10
267-279
-
17
Ratnavalli E, Brayne C, Dawson K. et al .
The prevalence of frontotemporal dementia.
Neurology.
2002;
58
1615-1621
-
18
McKhann G, Marilyn S, Grossmann M. et al .
Clinical and pathological diagnosis of frontotemporal dementia.
Arch Neurol.
2001;
58
1803
-
19
Diehl J, Kurz A.
Frontotemporal dementia: patient characteristics, cognition, and behavior.
Int J Geriatr Psychiatry.
2002;
17
914-918
-
20
Broe M, Hodges J R, Schofield E. et al .
Staging disease severity in pathologically confirmed cases of frontotemporal dementia.
Neurology.
2003;
60
1005-1011
-
21
Pickering-Brown S, Baker M, Yen S H. et al .
Pick's disease is associated with mutations in the tau gene.
Ann Neurol.
2000;
48
859-867
-
22
McKeith I, Del Ser T, Spano P. et al .
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double blind, placebo-controlled international study.
Lancet.
2000;
356
2031-2036
-
23
Winblad D, Poritis N.
Memantine in severe dementia. Results of the M-Best study.
Int J Geriatr Psychiatry.
1999;
14
135-146
Priv.-Doz. Dr. rer. nat. Dipl.-Psych. Rolf R. Diehl
Neurologische Klinik · Alfried Krupp Krankenhaus
Alfried-Krupp-Straße 21
45117 Essen
Email: Rolf.Diehl@Krupp-Krankenhaus.de
